Targeting cathepsin E in pancreatic cancer by a small molecule allows in vivo detection

Neoplasia (United States)

Volumn 15, Issue 7, 2013, Pages 684-693

  Keliher, Edmund J ^a   Reiner, Thomas ^a,b   Earley, Sarah ^a   Klubnick, Jenna ^a   Tassa, Carlos ^a   Lee, Andrew J ^c   Ramaswamy, Sridhar ^c   Bardeesy, Nabeel ^c   Hanahan, Douglas ^d   DePinho, Ronald A ^e   Castro, Cesar M ^a,c   Weissleder, Ralph ^a,c  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

^b MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

^c HARVARD MEDICAL SCHOOL   (United States)

^d SWISS INST FOR EXP CANCER RESEARCH   (Switzerland)

^e UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CATHEPSIN E; CONTRAST MEDIUM; RITONAVIR; TETRA METHYL BODIPY; UNCLASSIFIED DRUG;

ARTICLE; CHEMORADIOTHERAPY; CONFOCAL MICROSCOPY; CONTROLLED STUDY; ELECTROSPRAY MASS SPECTROMETRY; FLOW CYTOMETRY; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; HUMAN CELL; HUMAN TISSUE; IC 50; IMMUNOFLUORESCENCE; IMMUNOHISTOCHEMISTRY; LIQUID CHROMATOGRAPHY; MOLECULAR DOCKING; MOUSE; NONHUMAN; PANCREAS ADENOCARCINOMA; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SIMULATION; SURFACE PLASMON RESONANCE; WESTERN BLOTTING;

EID: 84879645313     PISSN: 15228002     EISSN: 14765586     Source Type: Journal    
DOI: 10.1593/neo.13276     Document Type: Article

References (26)

1. Vander Heiden MG, Cantley LC, and Thompson CB (2009). Understanding the Warburg effect: the metabolic requirements of cell proliferation. Science 324, 1029-1033.
2. 11C]-glutamine for metabolic imaging of tumors. J Nucl Med 53, 98-105.
3. Cruz-Monserrate Z, Abd-Elgaliel WR, Grote T, Deng D, Ji B, Arumugam T, Wang H, Tung CH, and Logsdon CD (2012). Detection of pancreatic cancer tumours and precursor lesions by cathepsin E activity in mouse models. Gut 61, 1315-1322.
4. Abd-Elgaliel WR, Cruz-Monserrate Z, Logsdon CD, and Tung CH (2011). Molecular imaging of cathepsin E-positive tumors in mice using a novel proteaseactivatable fluorescent probe. Mol Biosyst 7, 3207-3213.
5. Abd-Elgaliel WR and Tung CH (2010). Selective detection of cathepsin E proteolytic activity. Biochim Biophys Acta 1800, 1002-1008.
6. Eser S, Messer M, Eser P, von Werder A, Seidler B, Bajbouj M, Vogelmann R, Meining A, von Burstin J, Algul H, et al. (2011). In vivo diagnosis of murine pancreatic intraepithelial neoplasia and early-stage pancreatic cancer by molecular imaging. Proc Natl Acad Sci USA 108, 9945-9950.
7. Sessa F, Bonato M, Frigerio B, Capella C, Solcia E, Prat M, Bara J, and Samloff IM (1990). Ductal cancers of the pancreas frequently express markers of gastrointestinal epithelial cells. Gastroenterology 98, 1655-1665.
8. Uno K, Azuma T, Nakajima M, Yasuda K, Hayakumo T, Mukai H, Sakai T, and Kawai K (2000). Clinical significance of cathepsin E in pancreatic juice in the diagnosis of pancreatic ductal adenocarcinoma. J Gastroenterol Hepatol 15, 1333-1338.
9. Azuma T, Yamada M, Murakita H, Nishikawa Y, Kohli Y, Yamamoto K, and Hori H (1995). Cathepsin E expressed in pancreatic cancer. Adv Exp Med Biol 362, 363-366.
10. Azuma T, Hirai M, Ito S, Yamamoto K, Taggart RT, Matsuba T, Yasukawa K, Uno K, Hayakumo T, and Nakajima M (1996). Expression of cathepsin E in pancreas: a possible tumor marker for pancreas, a preliminary report. Int J Cancer 67, 492-497.
11. Matsuo K, Kobayashi I, Tsukuba T, Kiyoshima T, Ishibashi Y, Miyoshi A, Yamamoto K, and Sakai H (1996). Immunohistochemical localization of cathepsins D and E in human gastric cancer: a possible correlation with local invasive and metastatic activities of carcinoma cells. Hum Pathol 27, 184-190.
12. Weissleder R, Tung CH, Mahmood U, and Bogdanov AJ (1999). In vivo imaging of tumors with protease-activated near-infrared fluorescent probes. Nat Biotechnol 17, 375-378.
13. Tung CH, Mahmood U, Bredow S, and Weissleder R (2000). In vivo imaging of proteolytic enzyme activity using a novel molecular reporter. Cancer Res 60, 4953-4958.
14. Kirsch DG, Dinulescu DM, Miller JB, Grimm J, Santiago PM, Young NP, Nielsen GP, Quade BJ, Chaber CJ, Schultz CP, et al. (2007). A spatially and temporally restricted mouse model of soft tissue sarcoma. Nat Med 13, 992-997.
15. Aikawa E, Aikawa M, Libby P, Figueiredo JL, Rusanescu G, Iwamoto Y, Fukuda D, Kohler RH, Shi GP, Jaffer FA, et al. (2009). Arterial and aortic valve calcification abolished by elastolytic cathepsin S deficiency in chronic renal disease. Circulation 119, 1785-1794.
16. Jaffer FA, Kim DE, Quinti L, Tung CH, Aikawa E, Pande AN, Kohler RH, Shi GP, Libby P, and Weissleder R (2007). Optical visualization of cathepsin K activity in atherosclerosis with a novel, protease-activatable fluorescence sensor. Circulation 115, 2292-2298.
17. Kempf DJ, Marsh KC, Denissen JF, McDonald E, Vasavanonda S, Flentge CA, Green BE, Fino L, Park CH, Kong XP, et al. (1995). ABT-538 is a potent inhibitor of human immunodeficiency virus protease and has high oral bioavailability in humans. Proc Natl Acad Sci USA 92, 2484-2488.
18. Kwan JC, Eksioglu EA, Liu C, Paul VJ, and Luesch H (2009). Grassystatins A-C from marine cyanobacteria, potent cathepsin E inhibitors that reduce antigen presentation. J Med Chem 52, 5732-5747.
19. Arnold K, Bordoli L, Kopp J, and Schwede T (2006). The SWISS-MODEL workspace: a web-based environment for protein structure homology modelling. Bioinformatics 22, 195-201.
20. Trott O and Olson AJ (2010). AutoDock Vina: improving the speed and accu racy of docking with a new scoring function, efficient optimization, and multithreading. J Comput Chem 31, 455-461.
21. Morris GM, Huey R, Lindstrom W, Sanner MF, Belew RK, Goodsell DS, and Olson A. J (2009). AutoDock4 and AutoDockTools4: automated docking with selective receptor flexibility. J Comput Chem 30, 2785-2791.
22. Lee S, Vinegoni C, Feruglio PF, and Weissleder R (2012). Improved intravital microscopy via synchronization of respiration and holder stabilization. J Biomed Opt 17, 96018-1.
23. Orth JD, Kohler RH, Foijer F, Sorger PK, Weissleder R, and Mitchison TJ (2011). Analysis of mitosis and antimitotic drug responses in tumors by in vivo microscopy and single-cell pharmacodynamics. Cancer Res 71, 4608-4616.
24. Tenti P, Romagnoli S, Silini E, Zappatore R, Giunta P, Stella G, and Carnevali L (1994). Cervical adenocarcinomas express markers common to gastric, intestinal, and pancreatobiliary epithelial cells. Pathol Res Pract 190, 342-349.
25. Ullmann R, Morbini P, Halbwedl I, Bongiovanni M, Gogg-Kammerer M, Papotti M, Gabor S, Renner H, and Popper HH (2004). Protein expression profiles in adenocarcinomas and squamous cell carcinomas of the lung generated using tissue microarrays. J using tissue microarrays. J Pathol 203, 798-807.
26. Reiner T, Thurber G, Gaglia J, Vinegoni C, Liew CW, Upadhyay R, Kohler RH, Li L, Kulkarni RN, Benoist C, et al. (2011). Accurate measurement of pancreatic islet β-cell mass using a second-generation fluorescent exendin-4 analog. Proc Natl Acad Sci USA 108, 12815-12820.